Cargando…
Distinct alterations of CD68(+)CD163(+) M2-like macrophages and myeloid-derived suppressor cells in newly diagnosed primary immune thrombocytopenia with or without CR after high-dose dexamethasone treatment
BACKGROUND: Although impaired myeloid-derived suppressor cells (MDSCs) recently have been studied in immune thrombocytopenia (ITP), another myeloid-derived cell population signified as M2 macrophages has not been investigated properly in ITP patients. In the present study, we intended to determine t...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5833082/ https://www.ncbi.nlm.nih.gov/pubmed/29499727 http://dx.doi.org/10.1186/s12967-018-1424-8 |
_version_ | 1783303422147035136 |
---|---|
author | Shao, Xia Wu, Boting Cheng, Luya Li, Feng Zhan, Yanxia Liu, Chanjuan Ji, Lili Min, Zhihui Ke, Yang Sun, Lihua Chen, Hao Cheng, Yunfeng |
author_facet | Shao, Xia Wu, Boting Cheng, Luya Li, Feng Zhan, Yanxia Liu, Chanjuan Ji, Lili Min, Zhihui Ke, Yang Sun, Lihua Chen, Hao Cheng, Yunfeng |
author_sort | Shao, Xia |
collection | PubMed |
description | BACKGROUND: Although impaired myeloid-derived suppressor cells (MDSCs) recently have been studied in immune thrombocytopenia (ITP), another myeloid-derived cell population signified as M2 macrophages has not been investigated properly in ITP patients. In the present study, we intended to determine the features of circulating M2-like macrophages, to examine its relationship with MDSCs, and to explore their prognostic values in ITP. METHODS: Peripheral blood mononuclear cells from healthy controls and primary ITP patients were isolated to test the circulating M2-like macrophages and MDSCs. The circulating M2-like macrophage population defined as CD68(+)CD163(+) and circulating MDSC population as CD11b(+)CD33(+)HLA-DR(−) were determined by flow cytometry. Plasma inflammatory cytokines were measured by multiplex ELISA. RESULTS: The percentages of MDSCs were found to be expanded in newly diagnosed patients of ITP, especially among those of the complete response (CR) group (p < 0.0001). Positive linear correlation was verified between percentages of M2-like macrophages and MDSCs. The same correlation was also determined in the CR group. After treatment, the percentages of M2-like macrophages and MDSCs were both increased significantly in CR group, while those patients among the PR + NR group manifested a significant numeric decrease of MDSCs but only a moderate decrease in M2-like macrophages. MIP-1α/CCL3 was negatively correlated with M2-like macrophages while MCP-1 possessed a positive correlation with M2-like macrophages, eotaxin-1/CCL11 was negatively correlated with MDSCs and interleukin-1β (IL-1β) was found to be negatively correlated with both M2-like macrophages and MDSCs. CONCLUSIONS: The present findings indicated critical roles of both circulating M2-like macrophages and MDSCs in ITP. The positive correlation between them might be related to inflammatory factors-mediated bidirectional interactions or partially due to their similar background patterns during differentiation. MIP-1α/CCL3, MCP-1, eotaxin-1/CCL11 and IL-1β might play a critical role in the expansion of both M2 macrophages and MDSCs population in ITP patients, which deserves further investigation. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12967-018-1424-8) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5833082 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-58330822018-03-05 Distinct alterations of CD68(+)CD163(+) M2-like macrophages and myeloid-derived suppressor cells in newly diagnosed primary immune thrombocytopenia with or without CR after high-dose dexamethasone treatment Shao, Xia Wu, Boting Cheng, Luya Li, Feng Zhan, Yanxia Liu, Chanjuan Ji, Lili Min, Zhihui Ke, Yang Sun, Lihua Chen, Hao Cheng, Yunfeng J Transl Med Research BACKGROUND: Although impaired myeloid-derived suppressor cells (MDSCs) recently have been studied in immune thrombocytopenia (ITP), another myeloid-derived cell population signified as M2 macrophages has not been investigated properly in ITP patients. In the present study, we intended to determine the features of circulating M2-like macrophages, to examine its relationship with MDSCs, and to explore their prognostic values in ITP. METHODS: Peripheral blood mononuclear cells from healthy controls and primary ITP patients were isolated to test the circulating M2-like macrophages and MDSCs. The circulating M2-like macrophage population defined as CD68(+)CD163(+) and circulating MDSC population as CD11b(+)CD33(+)HLA-DR(−) were determined by flow cytometry. Plasma inflammatory cytokines were measured by multiplex ELISA. RESULTS: The percentages of MDSCs were found to be expanded in newly diagnosed patients of ITP, especially among those of the complete response (CR) group (p < 0.0001). Positive linear correlation was verified between percentages of M2-like macrophages and MDSCs. The same correlation was also determined in the CR group. After treatment, the percentages of M2-like macrophages and MDSCs were both increased significantly in CR group, while those patients among the PR + NR group manifested a significant numeric decrease of MDSCs but only a moderate decrease in M2-like macrophages. MIP-1α/CCL3 was negatively correlated with M2-like macrophages while MCP-1 possessed a positive correlation with M2-like macrophages, eotaxin-1/CCL11 was negatively correlated with MDSCs and interleukin-1β (IL-1β) was found to be negatively correlated with both M2-like macrophages and MDSCs. CONCLUSIONS: The present findings indicated critical roles of both circulating M2-like macrophages and MDSCs in ITP. The positive correlation between them might be related to inflammatory factors-mediated bidirectional interactions or partially due to their similar background patterns during differentiation. MIP-1α/CCL3, MCP-1, eotaxin-1/CCL11 and IL-1β might play a critical role in the expansion of both M2 macrophages and MDSCs population in ITP patients, which deserves further investigation. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12967-018-1424-8) contains supplementary material, which is available to authorized users. BioMed Central 2018-03-02 /pmc/articles/PMC5833082/ /pubmed/29499727 http://dx.doi.org/10.1186/s12967-018-1424-8 Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Shao, Xia Wu, Boting Cheng, Luya Li, Feng Zhan, Yanxia Liu, Chanjuan Ji, Lili Min, Zhihui Ke, Yang Sun, Lihua Chen, Hao Cheng, Yunfeng Distinct alterations of CD68(+)CD163(+) M2-like macrophages and myeloid-derived suppressor cells in newly diagnosed primary immune thrombocytopenia with or without CR after high-dose dexamethasone treatment |
title | Distinct alterations of CD68(+)CD163(+) M2-like macrophages and myeloid-derived suppressor cells in newly diagnosed primary immune thrombocytopenia with or without CR after high-dose dexamethasone treatment |
title_full | Distinct alterations of CD68(+)CD163(+) M2-like macrophages and myeloid-derived suppressor cells in newly diagnosed primary immune thrombocytopenia with or without CR after high-dose dexamethasone treatment |
title_fullStr | Distinct alterations of CD68(+)CD163(+) M2-like macrophages and myeloid-derived suppressor cells in newly diagnosed primary immune thrombocytopenia with or without CR after high-dose dexamethasone treatment |
title_full_unstemmed | Distinct alterations of CD68(+)CD163(+) M2-like macrophages and myeloid-derived suppressor cells in newly diagnosed primary immune thrombocytopenia with or without CR after high-dose dexamethasone treatment |
title_short | Distinct alterations of CD68(+)CD163(+) M2-like macrophages and myeloid-derived suppressor cells in newly diagnosed primary immune thrombocytopenia with or without CR after high-dose dexamethasone treatment |
title_sort | distinct alterations of cd68(+)cd163(+) m2-like macrophages and myeloid-derived suppressor cells in newly diagnosed primary immune thrombocytopenia with or without cr after high-dose dexamethasone treatment |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5833082/ https://www.ncbi.nlm.nih.gov/pubmed/29499727 http://dx.doi.org/10.1186/s12967-018-1424-8 |
work_keys_str_mv | AT shaoxia distinctalterationsofcd68cd163m2likemacrophagesandmyeloidderivedsuppressorcellsinnewlydiagnosedprimaryimmunethrombocytopeniawithorwithoutcrafterhighdosedexamethasonetreatment AT wuboting distinctalterationsofcd68cd163m2likemacrophagesandmyeloidderivedsuppressorcellsinnewlydiagnosedprimaryimmunethrombocytopeniawithorwithoutcrafterhighdosedexamethasonetreatment AT chengluya distinctalterationsofcd68cd163m2likemacrophagesandmyeloidderivedsuppressorcellsinnewlydiagnosedprimaryimmunethrombocytopeniawithorwithoutcrafterhighdosedexamethasonetreatment AT lifeng distinctalterationsofcd68cd163m2likemacrophagesandmyeloidderivedsuppressorcellsinnewlydiagnosedprimaryimmunethrombocytopeniawithorwithoutcrafterhighdosedexamethasonetreatment AT zhanyanxia distinctalterationsofcd68cd163m2likemacrophagesandmyeloidderivedsuppressorcellsinnewlydiagnosedprimaryimmunethrombocytopeniawithorwithoutcrafterhighdosedexamethasonetreatment AT liuchanjuan distinctalterationsofcd68cd163m2likemacrophagesandmyeloidderivedsuppressorcellsinnewlydiagnosedprimaryimmunethrombocytopeniawithorwithoutcrafterhighdosedexamethasonetreatment AT jilili distinctalterationsofcd68cd163m2likemacrophagesandmyeloidderivedsuppressorcellsinnewlydiagnosedprimaryimmunethrombocytopeniawithorwithoutcrafterhighdosedexamethasonetreatment AT minzhihui distinctalterationsofcd68cd163m2likemacrophagesandmyeloidderivedsuppressorcellsinnewlydiagnosedprimaryimmunethrombocytopeniawithorwithoutcrafterhighdosedexamethasonetreatment AT keyang distinctalterationsofcd68cd163m2likemacrophagesandmyeloidderivedsuppressorcellsinnewlydiagnosedprimaryimmunethrombocytopeniawithorwithoutcrafterhighdosedexamethasonetreatment AT sunlihua distinctalterationsofcd68cd163m2likemacrophagesandmyeloidderivedsuppressorcellsinnewlydiagnosedprimaryimmunethrombocytopeniawithorwithoutcrafterhighdosedexamethasonetreatment AT chenhao distinctalterationsofcd68cd163m2likemacrophagesandmyeloidderivedsuppressorcellsinnewlydiagnosedprimaryimmunethrombocytopeniawithorwithoutcrafterhighdosedexamethasonetreatment AT chengyunfeng distinctalterationsofcd68cd163m2likemacrophagesandmyeloidderivedsuppressorcellsinnewlydiagnosedprimaryimmunethrombocytopeniawithorwithoutcrafterhighdosedexamethasonetreatment |